Aware (AWRE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Revenue for Q1 2026 was $3.4 million, down from $3.6 million in Q1 2025, mainly due to lower perpetual/software license revenue and underestimated market shifts.
Strategic transformation underway, focusing on a unified biometric orchestration platform and reducing legacy product investments.
Operating expenses rose to $7.0 million from $5.5 million year-over-year, including $0.7 million in one-time severance costs tied to restructuring and a shift to a platform-driven model.
Cost structure reset with $4 million in annualized expense reductions and a simplified go-to-market model.
Emphasis on liveness detection and identity assurance to address AI-driven threats in biometrics.
Financial highlights
Q1 2026 revenue was $3.4 million, down from $3.6 million year-over-year, mainly due to lower perpetual/software license revenue.
Net loss widened to $3.5 million ($0.16 per diluted share) from $1.6 million ($0.08 per share) year-over-year.
Adjusted EBITDA loss was $3.2 million, compared to $1.5 million in the prior year period.
Operating expenses rose to $7.0 million from $5.5 million, including higher compensation and severance costs.
Ended the quarter with $19.6 million in cash, cash equivalents, and marketable securities, with no debt.
Outlook and guidance
Operating expenses are expected to decrease by $4.0 million annually starting Q2 2026 due to cost-saving actions.
Near-term variability expected to continue as the business transitions to a platform-first model.
Expense reductions to become more visible in future quarters as strategic alignment progresses.
Focus remains on long-term growth and broader platform adoption rather than short-term results.
Management believes current liquidity is sufficient for at least the next twelve months.
Latest events from Aware
- Flat revenue, higher losses, but recurring revenue and certifications boosted market position.AWRE
Q4 20255 Mar 2026 - Q2 revenue up 36% with improved margins, recurring growth, and strong 2024 outlook.AWRE
Q2 20242 Feb 2026 - Recurring revenue up 29% YoY; $1M government deal and CEO transition shape Q4 outlook.AWRE
Q3 202417 Jan 2026 - Q1 2025 revenue fell to $3.6M and net loss widened as leadership and strategy shifted.AWRE
Q1 202527 Dec 2025 - Q4 revenue up 10% year-over-year; recurring revenue grew 9% and net loss improved 39%.AWRE
Q4 202416 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with strong board support.AWRE
Proxy Filing1 Dec 2025 - Director re-elections, executive pay, and auditor ratification headline the June 2025 meeting.AWRE
Proxy Filing1 Dec 2025 - Revenue declined and losses widened, but recurring revenue and innovation support future growth.AWRE
Q2 202516 Nov 2025 - Q3 2025 revenue up 33% to $5.1M, with improved losses and strong recurring revenue.AWRE
Q3 20255 Nov 2025